NewAmsterdam Pharma (NAMS) Revenue (2023 - 2026)
NewAmsterdam Pharma (NAMS) revenue from Mar 31, 2023 to Mar 31, 2026. The TTM NewAmsterdam Pharma (NAMS) revenue is $23M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
NewAmsterdam Pharma (NAMS) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -52.12% |
| 3 Years TTM | +37.78% |
| All Time TTM | +81.46% |
Annual Revenue change of NewAmsterdam Pharma (NAMS)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $3.04M | -86.49% |
| 2025 | $23M | -50.61% |
| 2024 | $46M | +223.35% |
| 2023 | $14M | -85.55% |
| 2022 | $98M | N/A |
| 2021 | $0 | N/A |
| 2020 | $0 | N/A |